Latest News

Infections are leading causes of joint replacement failures, often requiring additional surgeries, prolonged hospital stays, as well as emotional and financial strain on patients. For higher risk patients, such as individuals with diabetes, chronic kidney disease, or a history of tobacco use, many orthopedic surgeons prescribe an extended course of oral antibiotics for an additional week after the patient leaves the hospital. A Yale study published in The Journal of Arthroplasty found that this extra week of medication may not be needed.

For many patients diagnosed with avascular necrosis, the treatment pathway begins with a troubling reality. The disease is often discovered after damage has already started. Blood supply to the bone becomes compromised. Bone tissue begins to die. Over time, the joint weakens, collapses and, for many patients, eventually requires replacement. The conversation that follows is frequently less about preserving the joint than preparing for its eventual failure.

Personalized Medicine & Applied Engineering program provides woman with practical hand prosthetics.

A total of 18 orthopaedics & rehabilitation faculty members were named 2025 Health Care Research All-Stars by Avant-garde Health in a report that recognizes the outstanding physicians and hospitals whose contributions to health care research significantly enhance the quality of patient care.

As students from the third academic cohort of the nation’s first master’s degree in personalized medicine and applied engineering (PMAE) progress through a unique curriculum, the program’s co-director, Daniel Wiznia, MD, explains why advanced technology is playing a growing role between medicine and engineering.

The Blavatnik Fund for Innovation at Yale Ventures has awarded a research grant award to an interdisciplinary team of Yale researchers for a project titled, “Dynamic 3D Morphometric Analysis.” The two-year $150,000 grant, funded through the Blavatnik Fund for Innovation, was awarded to associate research scientist, Frank Buono, PhD, associate professor, Daniel Wiznia, MD, and research scientist, Steven Tommasini, PhD, at the Yale Innovation Summit in recognition of their impact through life-science acceleration.

Frank Buono, PhD, associate research scientist in psychiatry; Jose Cortes-Briones, PhD, assistant professor of psychiatry; and Emily Lee, MD, assistant professor adjunct of psychiatry, have been chosen to receive a 2024 Blavatnik Award by Yale Ventures.